The factor IX genes in four Japanese families with haemophilia B were analysed for the restriction fragment length polymorphisms (RFLPs) of TaqI, Xmnl and DdeI, using subcloned intragenic DNA fragments as probes (probes VIII and XIII). The factor IX genes in 12 patients with haemophilia B and three high-responder-inhibitor cases showed no size difference using a cDNA probe (cVII) when restricted by TaqI, EcoRI and HindlII. Complete gene deletions were observed in two other highresponder-inhibitor cases.
INTRODUCTION
The gene for coagulation factor IX has been identified and completely sequenced by Choo et al. (1982) , Anson et al. (1984) , Kurachi and Davie (1982) , Yoshitake et al. (1985) and Jaye el a/. (1983) . Also, the common polymorphic sites in the normal factor IX gene have been clarified Camerino et al., 1984; Giannelli et aL, 1984; Winship et al., 1984) , to which pathogenic genes for haemophilia B were detected to be linked in a number of families using subcloned DNA fragments as probes and a cDNA sequence. These restriction fragment length polymorphisms (RFLPs) are now used for the female carrier detection and the prenatal diagnosis (Camerino eta!., 1984; Giannelli et al., 1984; Winship et al., 1984; Camerino et al., 1985; Peake et al., 1984; Hay et al., 1986; Grunebaum et al., 1984; Brocker-Vriends et al., 1985) . Although the abnormal factor IX genes in haemophiliacs have been analysed by the several investigators, a partial or complete deletion of the genes was found mainly in the inhibitor patients (Giannelli et al., 1983; Hassan et al., 1985a Hassan et al., , 1985b Bernardi et al., 1985) . This paper described a study of the RFLPs in 10 Japanese families with haemophilia B, using subcloned intragenic DNA fragments of the factor IX gene as probes.
Also, the restriction fragment length in 14 patients with haemophilia B, including five inhibitor cases were observed.
MATERIALS AND METHODS

Subjects.
Eleven haemophilia B patients from 10 unrelated families, all of whom were treated in our clinic, consisted of six patients with severe form, two with the moderate or mild form, one with Bm form and two with inhibitor (alloantibody) type. The two inhibitor cases were high responders with more than 50 Bethesda units, one of whom had a temporary inhibitor with a peak of 78 Bethesda units that subsequently disappeared even when factor IX preparation was administered. The family members tested included the propositus, other patients if they existed, and the propositus' parents. All mothers were detected as definite carriers according to their family pedigrees and/or their haemostatic findings. Their DNAs were used for RFLPs analysis using subcloned DNA probes as described below.
DNAs from the 11 patients and three other inhibitor cases, were studied for the detection of abnormal restriction sites in their factor IX genes using a cDNA probe. These three inhibitor cases were all high-responders.
Gene probes. Both the subcloned factor IX gene probes VIII and XIII and the cDNA probe eVII provided by Prof. Brownlee of Oxford University were described by Giannelli et al. (1984) and Winship et aL (1984) . The probes VIii, XIII and eVII were cloned into the PvulI site of ampicillin-resistant plasmid vectors pATs, and were stabbed in E. coli MC1061 that were cultured in media with ampicillin. After chloramphenicol amplification, the plasmids were separated by sucrose centrifugation. Then the DNAs from the plasmids were separated by ethidium bromidecesium chloride centrifugation. After the excision of plasmids DNAs with the appropriate restriction enzymes described in Table 1 , factor IX probes were separated by agarose gel electrophoresis. The probes VIII, XIII and cVII were 2.5, 0.46 and 2.0 kb in length, respectively. They were radiolabeled by nick translation (Rigby et al., 1977) , and were denatured by heating before hybridisation.
RFLPs analysis. Whole citrated-blood, 10 to 20 ml, were frozen at -70~ After centrifugation, the precipitates were treated with SDS and proteinase K by the method of Grunebaum et al. (1984) . Then DNA was obtained by repeated phenol-chloroform extractions. DNA samples were then submitted to reaction with an appropriate restriction enzyme. Taql, XmnI and Ddel were used for RFLP analysis in the families using probes VIII and XIII, and Taql, EcoRI and HindIII were used for detection of the restriction fragment length in the patients' DNA using probe cVII. After ethanol precipitation and SDS treatment, samples were electrophoresed in 0.7~o agarose using a submarine apparatus. Then the DNA fragments in the gel were denatured by 0.5 M sodium hydroxide, and transferred onto a nitrocellulose membrane filter by Southern blotting (Southern, 1975) . After prehybridisation, the filter was hybridised with each radiolabeled gene probe, and used for autoradiography (Table 2) .
R E S U L T S
RFLPs in the carriers restricted by TaqI, XmnI or DdeI TaqI, XmnI and DdeI polymorphisms in the two factor IX genes in the carriers of 10 haemophilia B families, were observed. All carriers were diagnosed by either their family pedigrees or by their haemostatic findings.
TaqI restriction is a typical way to detect a dimorphism of the gene, but only one carrier out of 10 showed dimorphism of fragment length. In the Xmnl restriction of the gene, the DNAs from two carriers out of the remaining nine, and in Ddel restriction, one carrier out of the remaining seven showed dimorphisms. Although Giannelli et al. (1984) and Winship et al. (1984) reported that approximately 6 0~ of haemophilia B genes could be detected in the families by observation of these three polymorphic sites, only four families out of 10 were informative by RFLP analysis of their factor IX genes in our observations.
Taql RFLP in a haemophilia B Jamily
A TaqI RFLP in a family is shown in Fig. 2 . The two genes in the mother (who was the carrier having 4 0~ IX :C plasma activity), showed a dimorphism of 5.3 + 1.8 and 5.3+ 1.3 kb, and the gene in the propositus (who has 1 -3~ plasma IX: C activity and 11~ IX antigen), was 5.3+1.8kb. Therefore the 5.3+1.8kb gene was detected as the pathogenic gene. And since the gene in the father showed 5.3+ 1.3 kb, the sister of the propositus, whose genes consisted of 5.3 + 1.3 from the father and 5.3 + 1.8 which was the pathogenic gene from the mother, was considered to be a carrier. Her clotting activity and antigen of factor IX were both approximately 4 0~. 
Xmnl and DdeI RFLPs in haemophilia B J'amilies
In XmnI restriction of a family, DNA from the mother showed a dimorphism of 11.5 and 6.5+5.0kb by probes VIII and XIII. Since the propositus and the brother who was also a patient of severe form, showed two small restricted bands of 6.5 + 5.0, this gene was determined as the pathogenic gene (Fig. 3) .
In the DdeI restriction of another family, the genes from the mother showed 1.75 and 1.70 kb. The former had a 50bp insertion. Since the propositus had 1.70 kb gene, it was the pathogenic gene. The genes from the sister who was already detected as a carrier according to her haemostatic findings, consisted of the abnormal gene of 1.70 kb from the mother and the normal gene of 1.75 kb from the father. The brother who was not a patient, had the normal gene of 1.75 kb from the mother (Fig. 4) .
Taql restriction of the patient genes
In order to observe either deletions of abnormalities of the restriction fragments of factor IX gene in the patients, DNAs from all patients were restricted by enzymes and their fragment length were detected using the cDNA probe cVII. This probe runs from residues 17 to 2,002 of the factor IX cDNA, so as to hybridise with the amino acid-coding exons. A total number of 14 patients including five inhibitor cases, was tested.
In the TaqI restriction, several positive bands consisting of three major bands of 3.5, 2.6 and 1.7 kb were observed in both normal and patient DNAs except two patients as is shown in Fig. 5 . Two inhibitor cases with high titers and one temporary inhibitor case were contained in these band-positive patients. The length of the positive fragment bands in the 12 patients was the same as that in normal s.~bjects, and corresponded to the sizes reported by Hassan et al. (1985a) . Though we can expect to find size differences if any partial deletion or mutation occurred in the TaqI TCGA site which includes a hot spot of mutation, no abnormality of the fragment length could be observed in comparison with those in the normal gene. In the remaining two inhibitor cases who were both high responders, no positive bands were detected with probe cVII hybridisation.
EcoRI restriction of the patient genes
As the next restriction enzyme for patient genes, we used EcoRi which attacks G/AATTC. As can be seen in Fig. 6 , three major fragments of 6.5, 5.2 and 4.5 kb nucleotides were observed except in two inhibitor cases. These fragment sizes of the gene were similar to those reported by Hassan et al. (1985b) , and no discrepancy of length was observed between the 12 tested subjects. In two inhibitor cases, no bands were detected as was found after TaqI digestion. 
HindlII restriction of the patient genes
As a final treatment with restriction enzyme, HindU[ was chosen to attack the A/AGCTT sequences. Several hot bands were observed on the film in both normal and patient genes except the previously mentioned two inhibitor cases, showing 15.3, 8.3, 6.0, 5.3, 4 .3 and 4.2 kb from the cathodal side. No size difference was detectable between the band-positive subjects. In the two inhibitor cases, no hybridisation bands were seen in HindIII restricted genes (Fig. 7) . Consequently, these two patients showed complete deletions of their factor IX genes.
DISCUSSION
The three common polymorphic sites of the factor IX gene are now thought to be very useful for the detection of the pathogenic gene in haemophilia B families (RFLP) Camerino et al., 1984; Winship et aL, 1984) . Many reports used for this purpose subcloned DNA and cDNA probes Giannelli et al., 1984; Winship et al., 1984; Camerino et at., 1985; Peake et al., 1984; Hay et al., 1986; Grunebaum eta[., 1984; Brocker-Vriends et al., 1985) . A TaqI site (T/CGA) in intron D is a typical polymorphic site Giannelli et aL, 1984) , and one of the hot spots of mutations (Barker et al., 1984) . Though approximately 25~o of the two factor IX genes in women are reported to have dimorphism in this site, only one carrier out of 10 showed it in our observation. All the remaining carriers showed a monomorphism of 2 x (5.3 and 1.8 kb). In this family, the pathogenic gene which showed 5.3 and 1.3 kb fragments must be inherited from the mother of the propositus. The sister of the propositus who was detected as a carrier according to her haemostatic findings, proved to have two factor IX genes consisting of one abnormal gene of 5.3 and 1.3 kb from the mother and the other normal gene of 5.3 and 1.8 kb from the father. Since the propositus showed 1-3~ activity but 11~ antigen, it seems difficult to perform prenatal diagnosis by the conventional method.
In XrnnI and DdeI RFLP analysis, the rates of dimorphisms in the carriers were also lower in our observation than those reported by Winship et al. (1984) , and the fragment length of the genes in the most of carriers showed 2 x (11.5 kb) by XrnnI and 2 x (1.70 kb) by DdeI in contrast with the result reported by Winship et al. (1984) . Since only a small number of carriers were tested in this observation, it will be necessary to examine the frequency of the polymorphic alleles in a much larger samples of the Japanese population before predicting the usefullness of these RFLP's. We must make efforts to search appropriate enzymes and DNA markers for RFLPs of Japanese factor IX genes.
In regard to the abnormalities of the factor IX genes in haemophilia B patients, either a partial or a total deletion of factor IX gene was reported in inhibitor cases (Giannelli et al., 1983; Hassan et al., 1985a Hassan et al., , 1985b Bernardi et al., 1985) except in one family (Chen et al., 1985) . However all of the inhibitor cases do not show a detectable gene deletion. In our observations, the factor IX genes in two inhibitor cases out of five showed a complete deletion, whereas the remaining three cases had the total gene. They were all high responders, though one of them was a temporary inhibitor case.
Point mutations of the genes in haemophilia B patients were reported in the CRM-positive variant form, for example, factor IX Chapel Hill (Noyes et al., 1983) and factor IX Alabama (Davis et al., 1984) . Restriction enzymes such as TaqI are a useful marker to search for a point mutation, and several point mutations were reported in haemophilia A patients detected by the method of RFLP search (Antonarakis et al., 1985; Gitscher et al., 1985; Gitscher et al., 1986) . In haemophilia B genes, a definitive mutation point has not been found by screening using restriction enzymes. However a mutation in a splice junction was determined by the analysis of DNA sequence (Rees et al., 1985) . In our research, TaqI, EcoRI and HindIII were used for reaction with the genes of 12 patients, and no abnormal fragments were detected. It may be required to observe size difference of the fragments using other enzymes.
